Withdrawal notice to: ‘Effectiveness of recombinant human follicle-stimulating hormone (r-hFSH): recombinant human luteinizing hormone versus r-hFSH alone in assisted reproductive technology treatment cycles among women aged 35–40 years: A German database study’ [YBEOG 89C (2023) 102350]
Best Practice & Research in Clinical Obstetrics & Gynaecology（2023）
关键词
reproductive technology treatment cycles,luteinizing hormone,follicle-stimulating,r-hfsh
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要